Experience real-time quotes, in-depth charts, and analyst ratings

MARKET

PGEN

Precigen Inc

NASDAQ

1.660

+0.025

+1.53%

Closed 18:57 07/25 EDT

OPEN

1.660

PREV CLOSE

1.635

HIGH

1.690

LOW

1.620

VOLUME

549.26K

TURNOVER

52 WEEK HIGH

1.930

52 WEEK LOW

0.8354

MARKET CAP

419.02M

P/E (TTM)

-4.2608

AquaBounty Technologies Inc <AQB.OQ> expected to post a loss of $1.15 a share - Earnings Preview

AquaBounty Technologies Inc expected to post a loss of $1.15 a share - Earnings Preview. The company is expected to report a 87.3% decrease in quarterly revenue to $100 thousand from $788.43 thousand a year ago. The Harvard Massachusetts-based company will report results on July 30.

Reuters · 11h ago

Precigen Insiders Placed Bullish Bets Worth US$1.72m

In the last 12 months Precigen, Inc. Insiders bought US$998k worth of shares at a price of US$1.75 per share. In the last year there was more buying than selling of shares in Precigen. The company owns about US$15m of shares. Our analysis of the insider transactions at Precigen shows the company has grown in value over the past year. An insider's optimism about the company's prospects is a positive sign. Precigen is not the only stock insiders are buying.

Simply Wall St · 2d ago

Precigen To Spearhead First Potential Gene Therapy Launch

Phil Tennant will be responsible for commercial strategy and execution across US and global markets. His initial focus will be on driving commercial readiness activities for the potential launch of PRGN-2012 in recurrent respiratory papillomatosis. Company strengthens focus on building and optimizing commercial readiness and pre-launch activities.

Benzinga · 3d ago

Press Release: Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

Dow Jones · 3d ago

Weekly Report: what happened at PGEN last week (0715-0719)?

Weekly Report · 4d ago

BUZZ-U.S. STOCKS ON THE MOVE-Allstate, Quanta, First Industrial Realty

Wall Street's major indexes reversed early gains on Thursday. The Dow Jones Industrial Average was down 0.66% at 40,925.7. The top three S&P 500 percentage gainers were D.R. Horton, Barnes & Noble and First Industrial Realty.

Reuters · 07/18 17:56

BUZZ-U.S. STOCKS ON THE MOVE-Meta Platforms, Cintas, Toast

The Nasdaq and the S&P 500 bounced back on Thursday. An upbeat forecast from Taiwan Semiconductor Manufacturing lifted chip stocks after a sharp sell-off in the previous session. The Dow Jones Industrial Average was down 0.80% and the Nasdaq Composite was also down. Meta Platforms, Cintas and Toast are up.

Reuters · 07/18 16:49

Weekly Report: what happened at PGEN last week (0708-0712)?

Weekly Report · 07/15 09:22

About PGEN

Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms develops product candidates designed to target urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders and infectious diseases. It has developed a pipeline of therapies across multiple indications. The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well as royalty interests in therapeutics and therapeutic platforms from companies not controlled by the Company. Exemplar segment is composed of Exemplar Genetics LLC, doing business as Precigen Exemplar (Exemplar), its wholly owned subsidiary focused on developing research models and services for healthcare research applications.

Webull offers Precigen Inc stock information, including NASDAQ: PGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGEN stock methods without spending real money on the virtual paper trading platform.